Polymicrobial bloodstream infections a risk factor for mortality in neonates at the national hospital, Tanzania: A

Joel Manyahi1, Agricola Joachim1, Frank Msafiri1

  • 1Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Plos One
|April 16, 2024
PubMed
Abstract

Insights

Polymicrobial bloodstream infections (BSI) significantly increase mortality risk compared to monomicrobial BSI. Aggressive management is crucial for better patient outcomes and reduced hospital stays.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Public Health

Background:

  • Polymicrobial bloodstream infections (BSI) present treatment challenges due to reduced empiric antibiotic efficacy against multiple pathogens.
  • Understanding the comparative outcomes of polymicrobial versus monomicrobial BSIs is critical for optimizing patient care.

Purpose of the Study:

  • To compare clinical outcomes between patients diagnosed with polymicrobial BSI and those with monomicrobial BSI.
  • To identify independent risk factors associated with mortality in patients with BSIs.

Main Methods:

  • A retrospective case-control study was conducted at Muhimbili National Hospital from July 2021 to June 2022.
  • Patients with polymicrobial BSI (cases) were matched with three controls having monomicrobial BSI based on age, ward, and admission duration.
  • Logistic regression analysis was employed to determine independent risk factors for in-hospital and 30-day mortality.

Main Results:

  • Polymicrobial BSIs were independently associated with increased in-hospital mortality (aOR 2.37) and 30-day mortality (aOR 2.05).
  • In neonates, polymicrobial BSI was a significant risk factor for both in-hospital (aOR 5.08) and 30-day mortality (aOR 3.13).
  • Isolates frequently exhibited multidrug resistance (52%), and patients with polymicrobial BSI had a numerically longer hospital stay.

Conclusions:

  • Polymicrobial BSI is a significant independent risk factor for mortality.
  • Patients with polymicrobial BSI experience longer hospitalizations compared to those with monomicrobial BSI.
  • Clinicians should adopt a more aggressive management strategy for polymicrobial BSIs.